-
公开(公告)号:US20130065870A1
公开(公告)日:2013-03-14
申请号:US13665790
申请日:2012-10-31
申请人: Nuvo Research Inc.
发明人: Jagat Singh , Joseph Zev Shainhouse , Bradley S. Galer , Robert Dominic King-Smith , Lisa Marie Grierson , Maria Burian , Jonathan Wilkin , Edward Kisak , John M. Newsam
IPC分类号: A61K31/196 , A61P19/02 , A61K31/56 , A61P29/00 , A61K31/203 , A61K31/506
CPC分类号: A61K31/196 , A61K8/35 , A61K8/36 , A61K8/361 , A61K8/42 , A61K9/0014 , A61K31/10 , A61K45/06 , A61K47/10 , A61K47/20 , A61K47/38 , A61Q17/02 , A61Q17/04 , A61K2300/00
摘要: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
-
公开(公告)号:US20130059915A1
公开(公告)日:2013-03-07
申请号:US13668061
申请日:2012-11-02
申请人: NUVO RESEARCH INC.
发明人: Jagat Singh , Joseph Zev Shainhouse , Bradley S. Galer , Robert Dominic King-Smith , Lisa Marie Grierson , Maria Burian , Jonathan Wilkin , Edward Kisak , John M. Newsam
IPC分类号: A61K31/196 , B42D15/00 , A61P29/00
CPC分类号: A61K31/196 , A61K8/35 , A61K8/36 , A61K8/361 , A61K8/42 , A61K9/0014 , A61K31/10 , A61K45/06 , A61K47/10 , A61K47/20 , A61K47/38 , A61Q17/02 , A61Q17/04 , A61K2300/00
摘要: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
-
公开(公告)号:US09132110B2
公开(公告)日:2015-09-15
申请号:US13665790
申请日:2012-10-31
申请人: NUVO RESEARCH INC.
发明人: Jagat Singh , Joseph Zev Shainhouse , Bradley S. Galer , Robert Dominic King-Smith , Lisa Marie Grierson , Maria Burian , Jonathan Wilkin , Edward Kisak , John M. Newsam
IPC分类号: A61K31/10 , A61K31/196 , A61K45/06
CPC分类号: A61K31/196 , A61K8/35 , A61K8/36 , A61K8/361 , A61K8/42 , A61K9/0014 , A61K31/10 , A61K45/06 , A61K47/10 , A61K47/20 , A61K47/38 , A61Q17/02 , A61Q17/04 , A61K2300/00
摘要: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
摘要翻译: 该领域涉及可用于缓解疼痛的组合物,包括双氯芬酸溶液和凝胶制剂,特别是其使用方法,制品和试剂盒,其向用户提供临床前,临床和其他信息。
-
公开(公告)号:US08741956B2
公开(公告)日:2014-06-03
申请号:US13668061
申请日:2012-11-02
申请人: Nuvo Research Inc.
发明人: Jagat Singh , Joseph Zev Shainhouse , Bradley S. Galer , Robert Dominic King-Smith , Lisa Marie Grierson , Maria Burian , Jonathan Wilkin , Edward Kisak , John M. Newsam
IPC分类号: A01N37/10 , A61K31/19 , A01N41/10 , C07C63/04 , C07C315/00 , C07C317/00
CPC分类号: A61K31/196 , A61K8/35 , A61K8/36 , A61K8/361 , A61K8/42 , A61K9/0014 , A61K31/10 , A61K45/06 , A61K47/10 , A61K47/20 , A61K47/38 , A61Q17/02 , A61Q17/04 , A61K2300/00
摘要: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
摘要翻译: 该领域涉及可用于缓解疼痛的组合物,包括双氯芬酸溶液和凝胶制剂,特别是其使用方法,制品和试剂盒,其向用户提供临床前,临床和其他信息。
-
公开(公告)号:US08513304B2
公开(公告)日:2013-08-20
申请号:US13680623
申请日:2012-11-19
申请人: Nuvo Research Inc.
CPC分类号: A61K47/20 , A61K9/2886 , A61K31/19 , A61K31/195 , A61K31/40 , A61K31/444 , A61K31/5415 , A61K47/12 , A61K47/14 , A61K47/16
摘要: It has been discovered that certain combinations of compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of active agents. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. There is described herein a topical formulation comprising (i) an active agent selected from at least one of lidocaine and tetracaine; (ii) a first compound, and (iii) a second compound, wherein the first compound and second compound are different, and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate.
摘要翻译: 已经发现,化合物的某些组合是优异的渗透增强剂,因此,可以掺入局部制剂以促进活性剂的给药。 渗透增加的增加也可能导致制剂中皮肤刺激物的总浓度降低。 本文描述了局部制剂,其包含(i)选自利多卡因和丁卡因中的至少一种的活性剂; (ii)第一化合物和(iii)第二化合物,其中第一化合物和第二化合物不同,并且各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸 酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US09308181B2
公开(公告)日:2016-04-12
申请号:US13791460
申请日:2013-03-08
申请人: Nuvo Research Inc.
发明人: Edward T. Kisak , John M. Newsam , Dominic King-Smith , Pankaj Karande , Samir Mitragotri , Tejas Desai , Wade A. Hull
IPC分类号: A61K31/196 , A61K31/405 , A61K9/70 , A61K31/192 , A61K31/40 , A61K31/407 , A61K31/5415 , A61K47/14 , A61K31/19 , A61K31/195 , A61K31/444 , A61K9/00 , A61K9/06 , A61F7/03 , A61K47/12 , A61K47/18 , A61K47/20 , A61K45/06 , A61K31/568 , A61K31/137 , A61K31/167 , A61K31/245 , A61F7/02
CPC分类号: A61K9/703 , A61F7/03 , A61F2007/0261 , A61K9/0014 , A61K9/06 , A61K9/7084 , A61K31/137 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/195 , A61K31/196 , A61K31/245 , A61K31/40 , A61K31/405 , A61K31/407 , A61K31/444 , A61K31/5415 , A61K31/568 , A61K45/06 , A61K47/12 , A61K47/14 , A61K47/183 , A61K47/20 , A61K2300/00
摘要: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
摘要翻译: 本公开内容涉及局部制剂,透皮系统和相关方法。 在一个实施方案中,提供了包括局部麻醉剂,第一化合物和第二化合物的局部制剂。 第一化合物和第二化合物不同,各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US20150342871A1
公开(公告)日:2015-12-03
申请号:US14738554
申请日:2015-06-12
申请人: NUVO RESEARCH INC.
发明人: Servet Buyuktimkin , Nadir Buyuktimkin , Jagat Singh , John M. Newsam , Dominic King-Smith , Edward T. Kisak
CPC分类号: A61K9/0014 , A61K9/0017 , A61K9/06 , A61K31/137 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/186 , A61K47/20 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38
摘要: The present invention provides topical compositions, methods of preparation, and methods of treatment for onychomycosis. In certain specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a zwitterionic surfactant or charged derivative thereof; a carboxylic acid, a lower alcohol, and water. The acid is selected from a short-chain hydroxy acid, a short-chain fatty acid, and a mixture thereof. In certain other specific embodiments, the invention provides an anti-fungal pharmaceutical composition for topical application comprising an anti-fungal agent, a quarternary amino acid, a keratolytic agent; a lower alcohol; and water. In certain embodiments, the keratolytic agent is urea, ammonium thioglycolate, or a mixture thereof.
摘要翻译: 本发明提供局部用组合物,制备方法和治疗甲真菌病的方法。 在某些具体实施方案中,本发明提供用于局部施用的抗真菌药物组合物,其包含抗真菌剂,两性离子表面活性剂或其带电衍生物; 羧酸,低级醇和水。 酸选自短链羟基酸,短链脂肪酸及其混合物。 在某些其他具体实施方案中,本发明提供了用于局部应用的抗真菌药物组合物,其包含抗真菌剂,季铵氨基酸,角质分解剂; 低级酒精; 和水。 在某些实施方案中,角质分解剂是尿素,巯基乙酸铵或其混合物。
-
公开(公告)号:US20130337031A1
公开(公告)日:2013-12-19
申请号:US13791460
申请日:2013-03-08
申请人: Nuvo Research Inc.
发明人: Edward T. Kisak , John M. Newsam , Dominic King-Smith , Pankaj Karande , Samir Mitragotri , Tejas Desai , Wade A. Hull
IPC分类号: A61K9/70 , A61K31/405 , A61K31/5415 , A61K31/40 , A61K31/407 , A61K31/196 , A61K31/192
CPC分类号: A61K9/703 , A61F7/03 , A61F2007/0261 , A61K9/0014 , A61K9/06 , A61K9/7084 , A61K31/137 , A61K31/167 , A61K31/19 , A61K31/192 , A61K31/195 , A61K31/196 , A61K31/245 , A61K31/40 , A61K31/405 , A61K31/407 , A61K31/444 , A61K31/5415 , A61K31/568 , A61K45/06 , A61K47/12 , A61K47/14 , A61K47/183 , A61K47/20 , A61K2300/00
摘要: The present disclosure is drawn to topical formulations, transdermal systems, and related methods. In one embodiment, a topical formulation is provided that includes a local anesthetic, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
摘要翻译: 本公开内容涉及局部制剂,透皮系统和相关方法。 在一个实施方案中,提供了包括局部麻醉剂,第一化合物和第二化合物的局部制剂。 第一化合物和第二化合物不同,各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US20130079404A1
公开(公告)日:2013-03-28
申请号:US13680623
申请日:2012-11-19
申请人: Nuvo Research Inc.
CPC分类号: A61K47/20 , A61K9/2886 , A61K31/19 , A61K31/195 , A61K31/40 , A61K31/444 , A61K31/5415 , A61K47/12 , A61K47/14 , A61K47/16
摘要: It has been discovered that certain combinations of compounds are excellent penetration enhancers and, as such, can be incorporated in a topical formulation to facilitate administration of active agents. The increased penetration enhancement can also lead to a reduction in the total concentration of skin irritants in the formulation. There is described herein a topical formulation comprising (i) an active agent selected from at least one of lidocaine and tetracaine; (ii) a first compound, and (iii) a second compound, wherein the first compound and second compound are different, and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate.
摘要翻译: 已经发现,化合物的某些组合是优异的渗透增强剂,因此,可以掺入局部制剂以促进活性剂的给药。 渗透增加的增加也可能导致制剂中皮肤刺激物的总浓度降低。 本文描述了局部制剂,其包含(i)选自利多卡因和丁卡因中的至少一种的活性剂; (ii)第一化合物和(iii)第二化合物,其中第一化合物和第二化合物不同,并且各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸 酸,油酸甘油酯和月桂基磺基乙酸钠。
-
公开(公告)号:US20150297723A1
公开(公告)日:2015-10-22
申请号:US14578812
申请日:2014-12-22
申请人: Nuvo Research Inc.
发明人: Edward T. Kisak , John M. Newsam , Dominic King-Smith , Pankaj Karande , Samir Mitragotri , Wade A. Hull , Ngoc Truc-Chi Vo
IPC分类号: A61K47/18 , A61K47/14 , A61K47/12 , A61K31/573
CPC分类号: A61K31/573 , A61F7/03 , A61F2007/0261 , A61K8/361 , A61K8/37 , A61K8/375 , A61K8/42 , A61K8/463 , A61K9/0014 , A61K9/06 , A61K31/135 , A61K31/192 , A61K31/196 , A61K31/568 , A61K47/12 , A61K47/14 , A61K47/18 , A61K47/183 , A61K47/20 , A61Q19/00 , A61K31/167 , A61K2300/00 , A61K31/245
摘要: The present disclosure is drawn to topical formulations and related methods. In one embodiment, a topical formulation is provided that includes at least one corticosteroid, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.
摘要翻译: 本公开涉及局部制剂和相关方法。 在一个实施方案中,提供了包含至少一种皮质类固醇,第一化合物和第二化合物的局部制剂。 第一化合物和第二化合物不同,各自选自N-月桂酰肌氨酸,辛基硫酸钠,月桂酸甲酯,肉豆蔻酸异丙酯,油酸,油酸甘油酯和月桂基磺基乙酸钠。
-
-
-
-
-
-
-
-
-